Aggressive behavior of Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia

Laryngoscope

Volumn 124, Issue 9, 2014, Pages 2043-2048

  Tomaszewski, Jonathan M ^a   Gavriel, Haim ^a   Link, Emma ^a   Boodhun, Sholeh ^a   Sizeland, Andrew ^a   Corry, June ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

chronic lymphocytic leukemia; Cutaneous squamous cell carcinoma; immunosuppression; recurrence; survival

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE; RITUXIMAB;

ADULT; AGED; AGGRESSION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE INTERVAL; DISTANT METASTASIS; FEMALE; HUMAN; IN-TRANSIT METASTASIS; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PERINEURAL INVASION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECOND CANCER; SKIN CARCINOMA; VERY ELDERLY;

CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS SQUAMOUS CELL CARCINOMA; IMMUNOSUPPRESSION; RECURRENCE; SURVIVAL;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84906938069     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24586     Document Type: Article

References (37)

1. Rozman C, Montserrat E,. Chronic lymphocytic leukemia. N Engl J Med 1995; 333: 1052-1057.
2. Yamamoto JF, Goodman MT,. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control 2008; 19: 379-390.
3. Otley CC,. Non-Hodgkin lymphoma and skin cancer: a dangerous combination. Australas J Dermatol 2006; 47: 231-236.
4. Tsimberidou AM, Wen S, McLaughlin P, et al. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol 2009; 27: 904-910.
5. Levi F, Randimbison L, Te VC, La Vecchia C,. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996; 74: 1847-1850.
6. Royle J, Baade P, Joske D, Girschik J, Fritschi L,. Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study. Br J Cancer 2011; 105: 1076-1081.
7. Lomas A, Leonardi-Bee J, Bath-Hextall F,. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069-1080.
8. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG,. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006; 184: 6-10.
9. Alam M, Ratner D,. Cutaneous squamous-cell carcinoma. N Engl J Med 2001: 975-983.
10. Berg D, Otley CC,. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1-17; quiz 18-20.
11. Lott DG, Manz R, Koch C, Lorenz RR,. Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients. Transplantation 2010; 90: 683-687.
12. Veness MJ, Quinn DI, Ong CS, et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999; 85: 1758-1764.
13. Brantsch KD, Meisner C, Schonfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008; 9: 713-720.
14. Clayman GL, Lee JJ, Holsinger FC, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005; 23: 759-765.
15. Veness MJ, Porceddu S, Palme CE, Morgan GJ,. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 2007; 29: 621-631.
16. Forest VI, Clark JJ, Veness MJ, Milross C,. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer 2010; 116: 1298-1304.
17. Palme CE, O'Brien CJ, Veness MJ, McNeil EB, Bron LP, Morgan GJ,. Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2003; 129: 750-753.
18. Southwell KE, Chaplin JM, Eisenberg RL, McIvor NP, Morton RP,. Effect of immunocompromise on metastatic cutaneous squamous cell carcinoma in the parotid and neck. Head Neck 2006; 28: 244-248.
19. Oddone N, Morgan GJ, Palme CE, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer 2009; 115: 1883-1891.
20. Ch'ng S, Maitra A, Allison RS, et al. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma. J Surg Oncol 2008; 98: 101-105.
21. Clark JR, Rumcheva P, Veness MJ,. Analysis and Comparison of the 7th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System for Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck. Ann Surg Oncol 2012; 19: 4252-4258.
22. Weimar VM, Ceilley RI, Goeken JA,. Aggressive biologic behavior of basal- and squamous-cell cancers in patients with chronic lymphocytic leukemia or chronic lymphocytic lymphoma. J Dermatol Surg Oncol 1979; 5: 609-614.
23. Bridges N, Steinberg JJ,. Aggressive squamous cell carcinoma of the skin after chronic lymphocytic leukemia. J Surg Oncol 1986; 33: 27-30.
24. Perez-Reyes N, Farhi DC,. Squamous cell carcinoma of head and neck in patients with well-differentiated lymphocytic lymphoma. Cancer 1987; 59: 540-544.
25. Hartley BE, Searle AE, Breach NM, Rhys-Evans PH, Henk JM,. Aggressive cutaneous squamous cell carcinoma of the head and neck in patients with chronic lymphocytic leukaemia. J Laryngol Otol 1996; 110: 694-695.
26. Frierson HF Jr, Deutsch BD, Levine PA,. Clinicopathologic features of cutaneous squamous cell carcinomas of the head and neck in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol 1988; 19: 1397-1402.
27. Mehrany K, Weenig RH, Pittelkow MR, Roenigk RK, Otley CC,. High recurrence rates of squamous cell carcinoma after Mohs' surgery in patients with chronic lymphocytic leukemia. Dermatol Surg 2005; 31: 38-42; discussion 42.
28. Mehrany K, Weenig RH, Lee KK, Pittelkow MR, Otley CC,. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. J Am Acad Dermatol 2005; 53: 1067-1071.
29. Stasko T, Brown MD, Carucci JA, et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004; 30: 642-650.
30. O'Reilly Zwald F, Brown M,. Skin cancer in solid organ transplant recipients: Advances in therapy and management: Part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65: 263-279.
31. Rowe DE, Carroll RJ, Day CL,. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 1992; 26: 976-990.
32. Merritt RM, Williams MF, James TH, Porubsky ES,. Detection of cervical metastasis. A meta-analysis comparing computed tomography with physical examination. Arch Otolaryngol Head Neck Surg 1997; 123: 149-152.
33. Van den Brekel M, Stel H, Castelijns J, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990; 177: 379-384.
34. Tomaszewski JM, Lau E, Corry J,. Utility of positron emission tomography/computed tomography for nodal staging of cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. Am J Otolaryngol 2014; 35: 66-69.
35. D'Souza J, Clark J,. Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2011; 19: 99-105.
36. Wollina U,. Cetuximab in non-melanoma skin cancer. Expert Opin Biol Ther 2012; 12: 949-956.
37. Lewis CM, Glisson BS, Feng L, et al. A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck. Clin Cancer Res 2012; 18: 1435-1446.